1. Home
  2. ICHR vs CRVS Comparison

ICHR vs CRVS Comparison

Compare ICHR & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$48.43

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$17.92

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
CRVS
Founded
1999
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2016
2016

Fundamental Metrics

Financial Performance
Metric
ICHR
CRVS
Price
$48.43
$17.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$40.67
$28.00
AVG Volume (30 Days)
1.2M
1.3M
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$947,652,000.00
N/A
Revenue This Year
$16.08
N/A
Revenue Next Year
$11.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.61
N/A
52 Week Low
$13.15
$2.54
52 Week High
$55.00
$26.95

Technical Indicators

Market Signals
Indicator
ICHR
CRVS
Relative Strength Index (RSI) 63.67 51.83
Support Level $15.70 $16.15
Resistance Level N/A $26.95
Average True Range (ATR) 4.08 1.03
MACD -0.32 -0.42
Stochastic Oscillator 55.63 41.60

Price Performance

Historical Comparison
ICHR
CRVS

About ICHR Ichor Holdings

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: